Melatonin and 1400 W Ameliorate both Intestinal and Remote Organ Injury Following Mesenteric Ischemia/Reperfusion

Journal of Surgical Research

Volumn 157, Issue 1, 2009, Pages

  Kesik, Vural ^a   Guven, Ahmet ^a   Vurucu, Sabahattin ^a   Tunc, Turan ^a   Uysal, Bulent ^a   Gundogdu, Gokhan ^a   Oztas, Emin ^a   Korkmaz, Ahmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

1400W; inducible nitric oxide synthase inhibitor, ischemia reperfusion injury; intestine; lung; melatonin; remote organ

Indexed keywords

3 NITROTYROSINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELATONIN; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; W 4262;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; INTESTINE INJURY; INTESTINE ISCHEMIA; KIDNEY; LIVER; LUNG INJURY; MALE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

AMIDINES; ANIMALS; ANTIOXIDANTS; BENZYLAMINES; ENZYME INHIBITORS; GLUTATHIONE PEROXIDASE; INTESTINES; KIDNEY; LIVER; LUNG; MALE; MALONDIALDEHYDE; MELATONIN; MESENTERIC VASCULAR OCCLUSION; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; SURVIVAL RATE; TYROSINE;

EID: 70349904408     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.12.024     Document Type: Article

References (53)

1. Menon N.J., Amin A.M., Mohammed A., et al. Acute mesenteric ischemia. Acta Chir Belg 105 (2005) 344
2. Schoenberg M.H., and Beger H.G. Reperfusion injury after intestinal ischemia. Crit Care Med 21 (1993) 1376
3. Guven A., Tunc T., Topal T., et al. α-Lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today 38 (2008) 1029
4. Mallick I.H., Yang W., Winslet M.C., et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 49 (2004) 1359
5. Li C., and Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282 (2002) C227
6. Deitch E.A., Forsythe R., Anjaria D., et al. The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock. Shock 22 (2004) 221
7. Rotstein OD. Pathogenesis of multiple organ dysfunction syndrome: Gut origin, protection, and decontamination. Surg Infect (Larchmt) 200;1:217; discussion 223.
8. Weidig P., McMaster D., and Bayraktutan U. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes Metab 6 (2004) 432
9. Cooke C.L., and Davidge S.T. Peroxynitrite increases iNOS through NF- κB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 282 (2002) C395
10. Stockklauser-Farber K., Ballhausen T., Laufer A., et al. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta 1535 (2000) 10
11. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1994) 109
12. Guven A., Uysal B., Akgul O., et al. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail 30 (2008) 747
13. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide peroxynitrite: The good, the bad, and ugly. Am J Physiol 271 (1996) C1424
14. Barocelli E., Ballabeni V., Ghizzardi P., et al. The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide 14 (2006) 212
15. Messina A., Knight K.R., Dowsing B.J., et al. Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab Invest 80 (2000) 423
16. Takimoto Y., Aoyama T., Keyamura R., et al. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int J Cardiol 76 (2000) 135
17. Iadecola C., Zhang F., Casey R., et al. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17 (1997) 9157
18. Isobe M., Katsuramaki T., Kimura H., et al. Role of inducible nitric oxide synthase on hepatic ischemia and reperfusion injury. Transplant Proc 32 (2000) 1650
19. Ling H., Edelstein C., Gengaro P., et al. Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 277 (1999) F383
20. Barker J.E., Knight K.R., Romeo R., et al. Targeted disruption of the nitric oxide synthase 2 gene protects against ischemia/reperfusion injury to skeletal muscle. J Pathol 194 (2001) 109
21. Konturek S.J., Konturek P.C., et al. W. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 58 (2007) 381
22. Sahna E., Parlakpinar H., Ozturk F., et al. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res 31 (2003) 188
23. Sahna E., Parlakpinar H., Turkoz Y., et al. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 54 (2005) 491
24. Reiter R.J., and Tan D.X. Melatonin: A novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58 (2003) 10
25. Mark L.A., Robinson A.V., and Schulak J.A. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury. J Surg Res 129 (2005) 236
26. Ovechkin A.V., Lominadze D., Sedoris K.C., et al. Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol 99 (2005) 2423
27. Mura M., Andrade C.F., Han B., et al. Intestinal ischemia-reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock 28 (2007) 227
28. Yang J.C., Wang Z.W., Li C.L., et al. Multiple organ injury at early stage of intestinal and hepatic ischemia-reperfusion in rats. Di Yi Jun Yi Da Xue Xue Bao 24 (2004) 198
29. Cerqueira N.F., Hussni C.A., and Yoshida W.B. Pathophysiology of mesenteric ischemia/reperfusion: A review. Acta Cir Bras 20 (2005) 336
30. Reiter R.J., Tan D.X., Osuna C., et al. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 7 (2000) 444
31. Topal T., Oztas Y., Korkmaz A., et al. Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res 38 (2005) 272
32. Guven A., Demirbag S., Uysal B., Topal T., et al. Effect of 3-amino benzamide, a poly(adenosine diphosphate-ribose) polymerase inhibitor, in experimental caustic esophageal burn. J Pediatr Surg 43 (2008) 1474
33. Lowry O.H., Rosebrough N.J., Farr A.L., et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265
34. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351
35. Tunc T, Uysal B, Atabek C, et-al. Erdosteine and Ebselen As Useful Agents in Intestinal Ischemia/Reperfusion Injury. J Surg Res doi:10.1016/j.jss.2008.06.017.
36. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62
37. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497
38. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158
39. Chiu C.J., McArdle A.H., Brown R., et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101 (1970) 478
40. Koksel O., Yildirim C., Cinel L., et al. Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats. Pharmacol Res 51 (2005) 453
41. Chatterjee P.K., Patel N.S., Kvale E.O., et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61 (2002) 862
42. Tan D.X., Manchester L.C., Terron M.P., et al. One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J Pineal Res 42 (2007) 28
43. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995) 117
44. Cesaratto L., Vascotto C., Calligaris S., et al. The importance of redox state in liver damage. Ann Hepatol 3 (2004) 86
45. Reiter R.J., Tan D.X., Jou M.J., et al. Biogenic amines in the reduction of oxidative stress: Melatonin and its metabolites. Neuro Endocrinol Lett 29 (2008) 391
46. Rodriguez C., Mayo J.C., Sainz R.M., et al. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 36 (2004) 1
47. Reiter R.J., Tan D.X., and Maldonado M.D. Melatonin as an antioxidant: Physiology versus pharmacology. J Pineal Res 39 (2005) 215
48. Winiarska K., Fraczyk T., Malinska D., et al. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 40 (2006) 168
49. Lin W.Y., Levin R.M., Chichester P., et al. Effects of L-arginine and L-NAME on chronic partial bladder outlet obstruction in rabbit. Am J Physiol Regul Integr Comp Physiol 293 (2007) R2390
50. Colak C., Parlakpinar H., Ozer M.K., et al. Investigating the protective effect of melatonin on liver injury related to myocardial ischemia-reperfusion. Med Sci Monit 13 (2007) BR251
51. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., et al. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: Study design and rationale. Contemp Clin Trials 28 (2007) 532
52. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 32 (2004) 21
53. Alexander J.H., Reynolds H.R., Stebbins A.L., et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA 297 (2007) 1657